natgillin/translations-raw huggingface dataset:
Without prejudice to the obligations defined by Directive 91/414/EEC as a consequence of including an active substance in Annex I, Member States should be allowed a period of six months after inclusion to review existing provisional authorisations of plant protection products containing bifenazate or milbemectin to ensure that the requirements laid down by Directive 91/414/EEC, in particular in its Article 13 and the relevant conditions set out in Annex I, are satisfied. Member States should transform existing provisional authorisations into full authorisations, amend them or withdraw them in accordance with the provisions of Directive 91/414/EEC.
Brez poseganja v obveznosti, opredeljene v Direktivi 91/414/EGS kot posledica vključitve aktivne snovi v Prilogo I, je treba dovoliti državam članicam, da v roku šestih mesecev po vključitvi pregledajo obstoječe začasne registracije fitofarmacevtskih sredstev, ki vsebujejo bifenazat ali milbemektin, da se zagotovi izpolnjevanje zahtev iz Direktive 91/414/EGS, zlasti iz člena 13 in ustreznih pogojev iz Priloge I. Države članice morajo preoblikovati obstoječe registracije v dokončne registracije, jih spremeniti ali umakniti v skladu z določbami Direktive 91/414/EGS.
By derogation from the above deadline, a longer period should be provided for the submission and assessment of the complete Annex III dossier of each plant protection product for each intended use in accordance with the uniform principles laid down in Directive 91/414/EEC.
Z odstopanjem od zgoraj določenega roka je treba določiti daljše obdobje za predložitev in oceno celotne dokumentacije iz Priloge III vsakega fitofarmacevtskega sredstva za vsako nameravano uporabo v skladu z enotnimi načeli iz Direktive 91/414/EGS.
The inclusion of bifenazate in Annex I is based on a dossier covering the use of this active substance on ornamental plants in greenhouses.
Vključitev bifenazata v Prilogo I temelji na dokumentaciji o uporabi navedene aktivne snovi na okrasnih rastlinah v rastlinjakih.
Other uses are currently not adequately supported by data from the notifier and not all of the risks from such uses have shown to be adequately addressed under the criteria required by Annex VI.
Druge uporabe trenutno niso ustrezno podprte s podatki prijavitelja in pokazalo se je, da vsa tveganja drugih uporab niso ustrezno obravnavana, tj. ovrednotena po merilih, ki jih zahteva Priloga VI.
If Member States are to grant authorisations for other uses, they should therefore require the data and information necessary to prove that the uses are compatible with the criteria in Directive 91/414/EEC, in particular concerning the effect on human consumers and the environment.
Če države članice odobrijo registracije za druge uporabe, morajo zato zahtevati podatke in informacije, ki dokazujejo, da so te uporabe združljive z merili iz Direktive 91/414/EGS, zlasti glede vpliva na zdravje ljudi in okolje.
It is therefore appropriate to amend Directive 91/414/EEC accordingly.
Zato je primerno, da se Direktiva 91/414/EGS ustrezno spremeni.
Member States shall adopt and publish by 31 May 2006 at the latest the laws, regulations and administrative provisions necessary to comply with this Directive.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 31. maja 2006.
They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
Komisiji takoj sporočijo besedila navedenih predpisov in korelacijsko tabelo med navedenimi predpisi in to direktivo.
They shall apply those provisions from 1 June 2006.
Države članice predpise uporabljajo od 1. junija 2006.
Member States shall in accordance with Directive 91/414/EEC, where necessary, amend or withdraw existing authorisations for plant protection products containing bifenazate or milbemectin as active substances by 31 May 2006.
Države članice do 31. maja 2006 v skladu z Direktivo 91/414/EGS po potrebi spremenijo ali umaknejo obstoječe registracije fitofarmacevtskih sredstev, ki vsebujejo bifenazat ali milbemektin kot aktivni snovi.
By that date, they shall in particular verify that the conditions in Annex I to that Directive relating to bifenazate and milbemectin, respectively, are met, with the exception of those identified in part B of the entry concerning those active substances, and that the holder of the authorisation has, or has access to, a dossier satisfying the requirements of Annex II to that Directive in accordance with the conditions of Article 13.
Do tega datuma zlasti preverijo, da so izpolnjeni pogoji iz Priloge I k navedeni direktivi v zvezi z bifenazatom oziroma milbemektinom, razen tistih, ki so opredeljeni v delu B uvrstitve navedenih aktivnih snovi, in da ima imetnik registracije dokumentacijo ali dostop do dokumentacije, ki izpolnjuje zahteve iz Priloge II k navedeni Direktivi v skladu s pogoji iz člena 13.
By way of derogation from paragraph 1, for each authorised plant protection product containing bifenazate or milbemectin as either the only active substance or as one of several active substances all of which were listed in Annex I to Directive 91/414/EEC by 30 November 2005 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles provided for in Annex VI to Directive 91/414/EEC, on the basis of a dossier satisfying the requirements of Annex III to that Directive and taking into account part B of the entry in Annex I to that Directive concerning bifenazate and milbemectin, respectively.
Z odstopanjem od odstavka 1 države članice ponovno ovrednotijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje bifenazat ali milbemektin, bodisi kot edino aktivno snov bodisi kot eno od več aktivnih snovi, vključeno v Prilogo I k Direktivi 91/414/EGS najpozneje do 30. novembra 2005, in sicer v skladu z enotnimi načeli iz Priloge VI k Direktivi 91/414/EGS in na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k navedeni direktivi in ob upoštevanju dela B uvrstitve v Prilogi I k Direktivi glede bifenazata in milbemektina.
On the basis of that evaluation, they shall determine whether the product satisfies the conditions set out in Article 4(1)(b), (c), (d) and (e) of Directive 91/414/EEC.
Na podlagi navedenega ovrednotenja države članice presodijo, ali sredstvo izpolnjuje pogoje iz člena 4(1)(b), (c), (d) in (e) Direktive 91/414/EGS.
in the case of a product containing bifenazate or milbemectin as the only active substance, where necessary, amend or withdraw the authorisation by 31 May 2007 at the latest; or
v primeru, da fitofarmacevtsko sredstvo vsebuje bifenazat ali milbemektin kot edino aktivno snov, po potrebi spremenijo ali umaknejo registracijo najpozneje do 31. maja 2007; ali
in the case of a product containing bifenazate or milbemectin as one of several active substances, where necessary, amend or withdraw the authorisation by 31 May 2007 or by the date fixed for such an amendment or withdrawal in the respective Directive or Directives which added the relevant substance or substances to Annex I to Directive 91/414/EEC, whichever is the latest.
v primeru, da fitofarmacevtsko sredstvo vsebuje bifenazat ali milbemektin kot eno od več aktivnih snovi, po potrebi spremenijo ali umaknejo registracijo do 31. maja 2007 ali do datuma, določenega za tako spremembo ali umik v ustrezni direktivi ali direktivah, v katerih je bila zadevna snov ali so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS, pri čemer se upošteva poznejši datum.
This Directive shall enter into force on 1 December 2005.
Ta direktiva začne veljati 1. decembra 2005.
OJ L 230, 12.9.2000, p. 14.
UL L 230, 12.9.2000, str. 14.
In Annex I the following rows are added at the end of the table:
V Prilogi I se na konec tabele dodajo naslednje vrstice.
Common Name, Identification Numbers
Splošno ime, identifikacijske številke
CAS No 149877-41-8
CAS št. 149877-41-8
CIPAC No 736
CIPAC št. 736
Isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinoformate
Izopropil-2-(4-metoksibifenil-3-il) hidrazinoformat
1 December 2005
december 2005
In assessing applications to authorise plant protection products containing bifenazate for uses other than on ornamental plants in greenhouses, Member States shall pay particular attention to the criteria in Article 4(1)(b), and shall ensure that any necessary data and information is provided before such an authorization is granted.
Pri ocenjevanju vlog za registracijo fitofarmacevtskih sredstev, ki vsebujejo bifenazat in so namenjene drugačnim uporabam, kakor za okrasne rastline v rastlinjakih, so države članice posebno pozorne na merila iz člena 4(1)(b) in zagotovijo, da so pred registracijo predloženi vsi nujni podatki in informacije.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on bifenazate, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 3 June 2005 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepne ugotovitve poročila o pregledu za bifenazat in zlasti dodatkov I in II, kot so bili dokončno oblikovani v Stalnem odboru za prehranjevalno verigo in zdravje živali dne 3. junija 2005.
Milbemectin is a mixture of M.A3 and M.A4
Milbemektin je mešanica M.A3 in M.A4
CAS No
CAS št.
CIPAC No 660
CIPAC št. 660
M.A3: (10E,14E,16E,22Z)-(1R,4S,5’S,6R,6’R,8R,13R,20R,21R,24S)-21,24-dihydroxy-5’,6’,11,13,22-pentamethyl-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24] pentacosa-10,14,16,22-tetraene-6-spiro-2’-tetrahydropyran-2-one
M.A3: (10E,14E,16E,22Z)-(1R,4S,5’S,6R,6’R,8R,13R,20R,21R,24S)-21,24-dihidroksi-5’,6’,11,13,22-pentametil-3,7,19-trioksatetraciklo[15.6.1.14,8.020,24] pentakoza-10,14,16,22-tetraen-6-spiro-2’-tetrahidropiran-2-on
Only uses as acaricide or insecticide may be authorised.
Registrira se lahko samo kot akaricid ali insekticid.
For the implementation of the uniform principles of Annex VI, the conclusions of the review report on milbemectin, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 3 June 2005 shall be taken into account.
Za izvajanje enotnih načel iz Priloge VI se upoštevajo sklepne ugotovitve poročila o pregledu za milbemektin in zlasti dodatkov I in II, kot so bili dokončno oblikovani v Stalnem odboru za prehranjevalno verigo in zdravje živali dne 3. junija 2005.
Risk mitigation measures should be applied where appropriate.’
Po potrebi se uporabljajo ukrepi za zmanjšanje tveganja.“
Further details on identity and specification of active substances are provided in the review report.
Več podrobnosti o aktivnih snoveh in njihovi opredelitvi in specifikaciji določa poročilo o pregledu.
14,8020,24] pentacosa-10,14,16,22-tetraene-6-spiro-2’-tetrahydropyran-2-one
14,8020,24] pentakoza-10,14,16,22-tetraen-6-spiro-2’-tetrahidropiran-2-on
M.A4: (10E,14E,16E,22Z)-(1R,4S,5’S,6R,6’R,8R,13R,20R,21R,24S)-6’-ethyl-21,24-dihydroxy-5’,11,13,22-tetramethyl-3,7,19-trioxatetracyclo[15.6.1.
M.A4: (10E,14E,16E,22Z)-(1R,4S,5’S,6R,6’R,8R,13R,20R,21R,24S)-6’-etil-21,24-dihidroksi-5’,11,13,22-tetrametil-3,7,19-trioksatetraciklo[15.6.1.
Directive 2005/59/EC of the European Parliament and of the Council
Direktiva Evropskega parlamenta in Sveta 2005/59/ES
amending for the 28th time Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (toluene and trichlorobenzene)
o 28. spremembi Direktive Sveta 76/769/EGS o približevanju zakonov in drugih predpisov držav članic v zvezi z omejitvami pri trženju in uporabi nekaterih nevarnih snovi in pripravkov (toluen in triklorobenzen)
The risks presented to man and the environment by toluene and trichlorobenzene (TCB) have been assessed under Council Regulation (EEC) No 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances [3].
Tveganja, ki jih za človeka in okolje predstavljata toluen in triklorobenzen (TCB), so bila ocenjena v skladu z Uredbo Sveta (EGS) št. 793/93 z dne 23. marca 1993 o oceni in nadzoru tveganja, ki ga predstavljajo obstoječe snovi [3].
The risk evaluation identified a need to limit those risks, and the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE) confirmed that conclusion.
Ocena tveganja je pokazala potrebo po omejitvi teh tveganj, kar je potrdil tudi Znanstveni odbor za strupenost, strupenost za ekosisteme in okolje (CSTEE).
Commission Recommendation 2004/394/EC of 29 April 2004 on the results of the risk evaluation and the risk reduction strategies for the substances: acetonitrile; acrylamide; acrylonitrile; acrylic acid; butadiene; hydrogen fluoride; hydrogen peroxide; methacrylic acid; methyl methacrylate; toluene; trichlorobenzene [4], adopted within the framework of Regulation (EEC) No 793/93, contains a strategy for limiting risks of toluene and TCB, recommending restrictions to limit the risks from certain uses of these substances.
Priporočilo Komisije 2004/394/ES z dne 29. aprila 2004 o rezultatih ocene tveganja in strategijah za zmanjšanje tveganja za snovi: acetonitril, akrilamid, akrilonitril, akrilna kislina, butadien, vodikov fluorid, vodikov peroksid, metakrilna kislina, metil metakrilat, toluen, triklorobenzen [4], ki je bilo sprejeto v okviru Uredbe (EGS) št. 793/93, vsebuje strategijo omejitve tveganja za toluen in triklorobenzen (TCB) za zmanjšanje tveganja, povezanega z določeno uporabo teh snovi.
In order to protect human health and the environment, it therefore appears necessary that the placing on the market and the use of toluene and TCB should be restricted.
Da bi zavarovali zdravje ljudi in okolje je torej nujno, da se omeji trženje in uporaba toluena in TCB.
The aim of this Directive is to introduce harmonising measures with regard to toluene and TCB, which have as their object the proper functioning of the internal market whilst ensuring a high level of protection of human health and of the environment, as required by Article 95 of the Treaty.
Cilj te direktive je uvesti ukrepe usklajevanja glede toluena in TCB, katerih namen je zagotoviti pravilno delovanje notranjega trga ob zagotavljanju visoke ravni varovanja človekovega zdravja in okolja, kot je določeno v členu 95 Pogodbe.
This Directive is to apply without prejudice to Community legislation laying down minimum requirements for the protection of workers, contained in Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work [5], and individual directives based thereon, in particular Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work (14th individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) [6] and Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (sixth individual Directive within the meaning of Article 16(1) of Council Directive 89/391/EEC) [7].
Ta direktiva se uporablja brez poseganja v zakonodajo Skupnosti, ki določa minimalne zahteve za zaščito delavcev, ki so vsebovani v Direktivi Sveta 89/391/EGS z dne 12. junija 1989 o uvajanju ukrepov za spodbujanje izboljšav varnosti in zdravja delavcev pri delu [5] in posebnih direktivah, ki temeljijo na navedeni direktivi, zlasti Direktivi Sveta 98/24/ES z dne 7. aprila 1998 o varovanju zdravja in zagotavljanju varnosti delavcev pred tveganji zaradi izpostavljenosti kemičnim dejavnikom pri delu (štirinajsta posebna direktiva v smislu člena 16(1) Direktive 89/391/EGS) [6] in Direktivi Evropskega parlamenta in Sveta 2004/37/ES z dne 29. aprila 2004 o varovanju delavcev pred nevarnostmi zaradi izpostavljenosti rakotvornim ali mutagenim snovem pri delu (šesta posebna direktiva v smislu člena 16(1) Direktive Sveta 89/391/EGS) [7].
Directive 76/769/EEC [8] should be amended accordingly,
Direktivo Sveta 76/769/EGS [8] je treba ustrezno spremeniti –
Annex I to Directive 76/769/EEC shall be amended as set out in the Annex to this Directive.
Priloga I k Direktivi 76/769/EGS se spremeni, kakor je določeno v Prilogi k tej direktivi.
They shall apply these measures from 15 June 2007.
Države članice začnejo uporabljati te predpise od 15. junij 2007.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive, together with a table showing how the provisions of this Directive correspond to the national provisions adopted.
Države članice sporočijo Komisiji besedila temeljnih določb predpisov nacionalne zakonodaje, sprejetih na področju, ki ga ureja ta direktiva, skupaj s korelacijsko tabelo med določbami te direktive in določbami predpisov, sprejetih v nacionalni zakonodaji.
OJ C 120, 20.5.2005, p. 6.
UL C 120, 20.5.2005, str. 6.
Opinion of the European Parliament of 13 April 2005 (not yet published in the Official Journal) and Council Decision of 19 September 2005.
Mnenje Evropskega parlamenta z dne 13. aprila 2005 (še ni objavljeno v Uradnem listu) in Sklep Sveta z dne 19. septembra 2005.
Corrected version in OJ L 199, 7.6.2004, p. 41.
Popravljena različica v UL L 199, 7.6.2004, str. 41.
Corrected version in OJ L 229, 29.6.2004, p. 23.
Popravljena različica v UL L 229, 29.6.2004, str. 23.
The following points are added to Annex I of Directive 76/769/EEC:
Prilogi I k Direktivi 76/769/EGS se dodata naslednji točki:
CAS No 108-88-3
CAS št. 108-88-3
May not be placed on the market or used as a substance or constituent of preparations in a concentration equal to or higher than 0,1 % by mass in adhesives and spray paints intended for sale to the general public.
Se ne sme dajati v promet ali uporabljati kot snov ali sestavina pripravkov v koncentracijah, enakih ali večjih od 0,1 masnih % v lepilih in barvah v razpršilu, namenjenih za prodajo širši javnosti.
Trichlorobenzene
Triklorobenzen
CAS No 120-82-1
CAS št. 120-82-1
May not be placed on the market or used as a substance or constituent of preparations in a concentration equal to or higher than 0,1 % by mass for all uses except
Se ne sme dajati v promet ali uporabljati kot snov ali sestavina pripravkov v koncentracijah, enakih ali večjih od 0,1 masnih % za vse vrste uporabe, razen
as an intermediate of synthesis, or
kot intermediat pri sintezi, ali
as a process solvent in closed chemical applications for chlorination reactions, or
kot topilo pri reakciji kloriranja v zaprtih kemijskih sistemih ali
in the manufacture of 1,3,5 — trinitro — 2,4,6 — triaminobenzene (TATB)’
pri izdelavi 1,3,5-trinitro-2,4,6-triaminobenzena (TATB).“
Member States shall adopt and publish the laws, regulations and administrative provisions necessary to comply with this Directive before 15 December 2006. They shall forthwith inform the Commission thereof.
Države članice sprejmejo in objavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, najpozneje do 15. decembra 2006 O tem takoj obvestijo Komisijo.
Massive flows of dirty money can damage the stability and reputation of the financial sector and threaten the single market, and terrorism shakes the very foundations of our society.
Obsežni tokovi umazanega denarja lahko škodujejo stabilnosti in ugledu finančnega sektorja in ogrožajo notranji trg, terorizem pa pretresa temelje naše družbe.
The soundness, integrity and stability of credit and financial institutions and confidence in the financial system as a whole could be seriously jeopardised by the efforts of criminals and their associates either to disguise the origin of criminal proceeds or to channel lawful or unlawful money for terrorist purposes.
Prizadevanja storilcev kaznivih dejanj in njihovih družabnikov, da bi prikrili izvor protipravne premoženjske koristi ali pa zakonita ali nezakonita sredstva namenili za terorizem, lahko resno ogrozijo trdnost, integriteto in stabilnost kreditnih in finančnih ustanov ter zaupanje v finančni sistem kot celoto.
In order to avoid Member States' adopting measures to protect their financial systems which could be inconsistent with the functioning of the internal market and with the prescriptions of the rule of law and Community public policy, Community action in this area is necessary.
Na tem področju je treba sprejeti ukrep Skupnosti, da bi preprečili, da države članice z namenom, da bi zavarovale svoje finančne sisteme, sprejmejo ukrepe, ki niso v skladu z oblikovanjem notranjega trga ter s predpisi pravne države in javnim redom Skupnosti.
In order to facilitate their criminal activities, money launderers and terrorist financers could try to take advantage of the freedom of capital movements and the freedom to supply financial services which the integrated financial area entails, if certain coordinating measures are not adopted at Community level.
Brez sprejetja nekaterih usklajevalnih ukrepov na ravni Skupnosti bi si tisti, ki perejo denar, in tisti, ki financirajo terorizem, poskušali olajšati izvrševanje svojih kaznivih dejanj z izkoriščanjem prostega pretoka kapitala in svobode zagotavljanja finančnih storitev, ki ju vključuje integrirano finančno območje.
In order to respond to these concerns in the field of money laundering, Council Directive 91/308/EEC of 10 June 1991 on prevention of the use of the financial system for the purpose of money laundering [4] was adopted.
Z namenom poiskati rešitve za izpostavljene probleme na področju pranja denarja je bila sprejeta Direktiva Sveta 91/308/EGS z dne 10. junija 1991 o preprečevanju uporabe finančnega sistema za pranje denarja [4].
Money laundering and terrorist financing are frequently carried out in an international context.
Pranje denarja in financiranje terorizma se pogosto izvajata na mednarodni ravni.
The Community action should continue to take particular account of the Recommendations of the Financial Action Task Force (hereinafter referred to as the FATF), which constitutes the foremost international body active in the fight against money laundering and terrorist financing.
Ukrepi, sprejeti s strani Skupnosti na tem področju, naj predvsem upoštevajo priporočila Projektne skupine za finančno ukrepanje (v nadaljevanju „FATF“), ki predstavlja najpomembnejše mednarodno telo na področju boja proti pranju denarja in financiranju terorizma.
The General Agreement on Trade in Services (GATS) allows Members to adopt measures necessary to protect public morals and prevent fraud and adopt measures for prudential reasons, including for ensuring the stability and integrity of the financial system.
Splošni sporazum o trgovini s storitvami (GATS) članicam dovoljuje sprejetje ukrepov, potrebnih za zaščito javne morale in preprečevanje goljufij ter sprejetje ukrepov za varno in skrbno poslovanje ter za zagotavljanje trdnosti in celosti finančnega sistema.
Although initially limited to drugs offences, there has been a trend in recent years towards a much wider definition of money laundering based on a broader range of predicate offences.
Zadnja leta je opazna potreba po širši opredelitvi pranja denarja, sprva omejeni na nezakonito trgovanje z mamili, ki naj bi zajemala daljši seznam predhodnih kaznivih dejanj.
Furthermore, the misuse of the financial system to channel criminal or even clean money to terrorist purposes poses a clear risk to the integrity, proper functioning, reputation and stability of the financial system.
Nadalje zloraba finančnega sistema za preusmerjanje nezakonitih ali celo zakonitih sredstev za namene terorizma dejansko jasno ogroža celost, pravilno delovanje, ugled in stabilnost finančnega sistema.
Directive 91/308/EEC, though imposing a customer identification obligation, contained relatively little detail on the relevant procedures.
Direktiva 91/308/EGS je sicer predpisala obveznost identifikacije strank, vendar je predvidela sorazmerno malo podrobnosti o ustreznih postopkih.